Abstract:
A liquid crystal display includes an insulating substrate, gate and data lines formed on the substrate to define pixel areas, or collectively a display area. Gate signal interconnection wires are formed at a corner portion of the substrate outside the display area to transmit gate electrical signals, and provided with gate signal interconnection lines and first and second gate signal interconnection pads connected to both ends of the gate signal interconnection lines. A gate insulating layer, and a protective layer are further formed on the substrate, and provided with first and second contact holes exposing the first and second gate signal interconnection pads. Gate and data signal transmission films are attached to the substrate, and provided with first and second gate signal leads and first and second gate signal wires. The first and second gate signal leads are connected to the first and second gate signal interconnection pads through the first and second contact holes. The first or the second gate signal lead completely covers the first or the second contact hole at least in the longitudinal direction of the lead.
Abstract:
Provided is a liquid composition for treating stomatitis, the liquid composition including: an epidermal growth factor; an adhesive polymer; and at least one stabilizer selected from the group consisting of ethylenediaminetetraacetic acid (EDTA) and salts thereof, histidine, lysine and inorganic acid salts thereof, arginin and inorganic acid salts thereof, and dextran. The liquid composition includes a stabilizer selected from EDTA (or salts thereof) and a certain amino acid (or inorganic acid salts thereof) and thus, physicochemical and biological stability of the epidermal growth factor can be substantially increased. Thus, the liquid composition can be stored and distributed for a long period of time. The stabilized composition includes an adhesive polymer, and thus, when ejected in a spray form in the mouth of a user, the liquid composition can be quickly attached to an inflammation site and exhibits effectiveness for a long period of time.
Abstract:
Disclosed is a liquid crystal display device that includes: a blue phase mode liquid crystal layer between the first and second substrates, and has an optical anisotropy when an electric field is applied and not applied; polarizing plates on outer surfaces of first and second substrates, respectively; and one of a first optical compensation film including a +C plate, and a second optical compensation film including a biaxial phase retardation layer, between the polarizing plate and the liquid crystal panel.
Abstract:
A display device has a cover window that is light, has good resistance against external impact, and is capable of being processed with various shapes. A display device according to the present invention includes: a display panel including a display area and a non-display area; and a cover window positioned at the front side of the display panel and including a transparent area corresponding to the display area and a non-transparent area corresponding to the non-display area, wherein the cover window includes a cover window main body formed with the transparent area and the non-transparent area, and a transparent protection layer formed at the front surface of the cover window main body. The transparent protection layer extends to the rear surface corresponding to at least a portion of the non-transparent area of the cover window main body.
Abstract:
A mobile terminal having security diagnosis functionality and a method of making a diagnosis on the security of the mobile terminal are provided. The mobile terminal includes a system check unit, an interface unit, a blacklist check unit, and a security diagnosis unit. The system check unit collects the basic information of the mobile terminal by performing a system check on the mobile terminal. The interface unit provides the basic information of the mobile terminal to a user and receives a control command from the user. The blacklist check unit checks whether at least one application installed in the mobile terminal is present in a blacklist registered on a server. The security diagnosis unit checks whether an abnormality has occurred in the corresponding application based on results of the comparison between the basic information of the mobile terminal with preset abnormality detection reference information and the control command.
Abstract:
A backlight assembly comprises a light source unit emitting light, a heat-blocking plate disposed over the light source unit to prevent heat generated from the light source unit from being upwardly transmitted, and a receiving container receiving the light source unit and the heat-blocking plate. The receiving container includes a bottom plate and a plurality of sidewalls. Each of the sidewalls extends from a side of the bottom plate and has openings formed through each of the sidewalls. The openings are formed over the heat-blocking plate.
Abstract:
The present invention relates to 6-(4-substituted-anilino)pyrimidine derivatives useful as an antiviral agent, and more particularly novel 6-(4-substituted-anilino)pyrimidine derivatives having an excellent inhibitory effect on replication of Hepatitis C virus; HCV), represented by the following formula I: in which R represents a C1-C4 straight or branched alkoxycarbonyl group, heterocycliccarbonyl group or carboxyalkyl group; and pharmaceutically acceptable salts thereof, a preparation method thereof, and an antiviral pharmaceutical composition comprising the compound as an effective ingredient. The 6-(4-substituted-anilino)pyrimidine derivatives according to the present invention have an excellent inhibitory effect on replication of Hepatitis C virus (HCV) and thus can be advantageously used as a therapeutic or prophylactic agent of hepatitis C.
Abstract:
A micromachined cell lysis device with electrodes that are spaced by less than 10 μm from one another. The cells are attracted to the space between the electrodes and then lysed.
Abstract:
A liquid crystal display includes an insulating substrate, gate and data lines formed on the substrate to define pixel areas, or collectively a display area. Gate signal interconnection wires are formed at a corner portion of the substrate outside the display area to transmit gate electrical signals, and provided with gate signal interconnection lines and first and second gate signal interconnection pads connected to both ends of the gate signal interconnection lines. A gate insulating layer, and a protective layer are further formed on the substrate, and provided with first and second contact holes exposing the first and second gate signal interconnection pads. Gate and data signal transmission films are attached to the substrate, and provided with first and second gate signal leads and first and second gate signal wires. The first and second gate signal leads are connected to the first and second gate signal interconnection pads through the first and second contact holes. The first or the second gate signal lead completely covers the first or the second contact hole at least in the longitudinal direction of the lead.
Abstract:
The present invention relates to novel 6-methylnicotinamide derivatives and their pharmaceutically acceptable salts, the process for preparing them, and the pharmaceutical compositions containing said compounds as active ingredients. The 6-methylnicotinamide derivatives of the present invention exhibit their inhibitory activity against the proliferation of human immunodeficiency virus (HIV) as well as hepatitis B virus (HBV) and hepatitis C virus (HCV), such that they can be used for hepatitis B, hepatitis C and acquired immune deficiency syndrome (AIDS).